CLINICAL
Learn
AI-Powered Solutions for Personalized Patient Care.
We’re developing a future suite of AI-powered products–built on the identifeye Platform–to deliver personalized preventative healthcare solutions. Our AI toolkit will unlock valuable insights in the retina to address some of today’s most pressing healthcare challenges.
IDENTIFEYE DR
Point-of-Care Screening for Diabetic Retinopathy
The first algorithm we’re developing will screen for more-than-mild diabetic retinopathy. It will enable automated, real-time detection of signs of diabetic retinopathy (DR) at the point-of-care, often before the appearance of symptoms for the patient.
Learn More About Diabetic Retinopathy
DR is the leading cause of preventable blindness in American adults.¹ Preventing vision loss starts with early detection.
AI-Powered Screening and Monitoring Products
A future suite of AI-powered screening and monitors tools will unlock advanced clinical insights at the point-of-care.
References:
- Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TKS, de Clerck E, Polivka J Jr, Potuznik P, Polivka J, Stetkarova I, Kubatka P, Thumann G. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023 Feb 13;14(1):21-42. doi: 10.1007/s13167-023-00314-8. PMID: 36866156; PMCID: PMC9971534.